1. Hu, Li, Wang, Jie, Huang, Huijie, Fulton, David J R, Chen, Feng. . YTHDF1 Regulates Pulmonary Hypertension through Translational Control of MAGED1. In American journal of respiratory and critical care medicine, 203, 1158-1172. doi:10.1164/rccm.202009-3419OC. https://pubmed.ncbi.nlm.nih.gov/33465322/
2. Wang, Qinghua, Tang, Jing, Jiang, Shujun, Gao, Xiang, Ruan, Hai-Bin. . Inhibition of PPARγ, adipogenesis and insulin sensitivity by MAGED1. In The Journal of endocrinology, 239, 167-180. doi:10.1530/JOE-18-0349. https://pubmed.ncbi.nlm.nih.gov/30121577/
3. Dombret, Carlos, Nguyen, Tuan, Schakman, Olivier, Bertrand, Mathieu J M, De Backer, Olivier. 2012. Loss of Maged1 results in obesity, deficits of social interactions, impaired sexual behavior and severe alteration of mature oxytocin production in the hypothalamus. In Human molecular genetics, 21, 4703-17. doi:10.1093/hmg/dds310. https://pubmed.ncbi.nlm.nih.gov/22865874/
4. De Backer, Jean-François, Monlezun, Stéphanie, Detraux, Bérangère, Schiffmann, Serge N, de Kerchove d'Exaerde, Alban. 2018. Deletion of Maged1 in mice abolishes locomotor and reinforcing effects of cocaine. In EMBO reports, 19, . doi:10.15252/embr.201745089. https://pubmed.ncbi.nlm.nih.gov/30002119/
5. Wang, Xiaohan, Tang, Jing, Xing, Lijuan, Gao, Xiang, Xu, Ying. 2010. Interaction of MAGED1 with nuclear receptors affects circadian clock function. In The EMBO journal, 29, 1389-400. doi:10.1038/emboj.2010.34. https://pubmed.ncbi.nlm.nih.gov/20300063/